PNC Financial Services Group’s Galectin Therapeutics GALT Stock Holding History

PNC Financial Services Group’s Portfolio GALT Stock Details GALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,000	Closed	-$24.4K	–	4974
2025 Q1	$24.4K	Hold	20,000	–	–	﹤0.01%	3457
2024 Q4	$25.8K	Buy	+20,000	New	+$25.8K	﹤0.01%	3413
2023 Q4	–	Sell	-56,184	Closed	-$108K	–	4680
2023 Q3	$108K	Hold	56,184	–	–	﹤0.01%	2525
2023 Q2	$80.9K	Hold	56,184	–	–	﹤0.01%	2770
2023 Q1	$118K	Hold	56,184	–	–	﹤0.01%	2469
2022 Q4	$63.5K	Hold	56,184	–	–	﹤0.01%	2838
2022 Q3	$92K	Hold	56,184	–	–	﹤0.01%	2588
2022 Q2	$74K	Hold	56,184	–	–	﹤0.01%	2764
2022 Q1	$90K	Buy	56,184 +10,000	+22%	+$16K	﹤0.01%	2772
2021 Q4	$96K	Hold	46,184	–	–	﹤0.01%	2716
2021 Q3	$179K	Sell	46,184 -345	-0.7%	-$1.34K	﹤0.01%	2267
2021 Q2	$149K	Buy	46,529 +345	+0.7%	+$1.11K	﹤0.01%	2409
2021 Q1	$100K	Hold	46,184	–	–	﹤0.01%	2578
2020 Q4	$103K	Sell	46,184 -21,784	-32%	-$48.6K	﹤0.01%	2462
2020 Q3	$181K	Hold	67,968	–	–	﹤0.01%	1994
2020 Q2	$208K	Hold	67,968	–	–	﹤0.01%	1903
2020 Q1	$133K	Hold	67,968	–	–	﹤0.01%	2046
2019 Q4	$194K	Hold	67,968	–	–	﹤0.01%	2089
2019 Q3	$249K	Buy	67,968 +3,000	+5%	+$11K	﹤0.01%	2009
2019 Q2	$270K	Buy	64,968 +17,804	+38%	+$74K	﹤0.01%	1981
2019 Q1	$241K	Hold	47,164	–	–	﹤0.01%	2034
2018 Q4	$162K	Hold	47,164	–	–	﹤0.01%	2178
2018 Q3	$283K	Sell	47,164 -5,000	-10%	-$30K	﹤0.01%	2002
2018 Q2	$332K	Buy	52,164 +980	+2%	+$6.24K	﹤0.01%	1893
2018 Q1	$243K	Hold	51,184	–	–	﹤0.01%	2056
2017 Q4	$171K	Buy	+51,184	New	+$171K	﹤0.01%	2280
2016 Q3	–	Sell	-200	Closed	–	–	4091
2016 Q2	$0	Buy	+200	New	–	﹤0.01%	4513
2015 Q4	–	Sell	-317	Closed	-$1K	–	4503
2015 Q3	$1K	Hold	317	–	–	﹤0.01%	4458
2015 Q2	$1K	Buy	317 +135	+74%	+$426	﹤0.01%	4546
2015 Q1	$1K	Buy	+182	New	+$1K	﹤0.01%	4479